company background image
1952 logo

Everest Medicines SEHK:1952 Stock Report

Last Price

HK$18.18

Market Cap

HK$5.8b

7D

14.3%

1Y

-1.3%

Updated

20 Feb, 2024

Data

Company Financials +

Everest Medicines Limited

SEHK:1952 Stock Report

Market Cap: HK$5.8b

1952 Stock Overview

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

1952 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Everest Medicines Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Everest Medicines
Historical stock prices
Current Share PriceHK$18.18
52 Week HighHK$32.20
52 Week LowHK$10.32
Beta2.13
1 Month Change7.07%
3 Month Change-30.08%
1 Year Change-1.30%
3 Year Change-79.29%
5 Year Changen/a
Change since IPO-75.01%

Recent News & Updates

A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Jan 31
A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Recent updates

A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Jan 31
A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Sep 26
A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)

Shareholder Returns

1952HK BiotechsHK Market
7D14.3%4.2%2.5%
1Y-1.3%-48.3%-17.8%

Return vs Industry: 1952 exceeded the Hong Kong Biotechs industry which returned -48.3% over the past year.

Return vs Market: 1952 exceeded the Hong Kong Market which returned -17.8% over the past year.

Price Volatility

Is 1952's price volatile compared to industry and market?
1952 volatility
1952 Average Weekly Movement10.4%
Biotechs Industry Average Movement9.5%
Market Average Movement7.0%
10% most volatile stocks in HK Market14.5%
10% least volatile stocks in HK Market3.4%

Stable Share Price: 1952's share price has been volatile over the past 3 months.

Volatility Over Time: 1952's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
2017395Rogers Luohttps://www.everestmedicines.com

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include 9 clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. The company offers Nefecon, an oral formulation of budesonide for the treatment of primary immunoglobulin nephropathy (IgAN); EVER001, a covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor which is in the phase 1b/2 clinical trial for the treatment of renal diseases; PTX-COVID19-B, a lipid nanoparticle-formulated mRNA COVID-19 vaccine; EVER-COVID19-M1, an Omicron-targeting bivalent COVID-19 booster vaccine; and mRNA rabies vaccine.

Everest Medicines Limited Fundamentals Summary

How do Everest Medicines's earnings and revenue compare to its market cap?
1952 fundamental statistics
Market capHK$5.83b
Earnings (TTM)-HK$3.10m
Revenue (TTM)HK$22.44m

259.7x

P/S Ratio

-1,879x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1952 income statement (TTM)
RevenueCN¥20.64m
Cost of RevenueCN¥7.60m
Gross ProfitCN¥13.04m
Other ExpensesCN¥15.90m
Earnings-CN¥2.85m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0089
Gross Margin63.19%
Net Profit Margin-13.82%
Debt/Equity Ratio4.9%

How did 1952 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.